Literature DB >> 1548360

Diminished growth hormone-binding protein in children with insulin-dependent diabetes mellitus.

R K Menon1, S Arslanian, B May, W S Cutfield, M A Sperling.   

Abstract

Two distinct GH-binding proteins (GHBP) are present in circulation in the human. The major GHBP (high affinity GHBP) is homologous to the extracellular portion of the GH receptor and the concentration of this protein in circulation may reflect the status of the GH receptor in the tissues. To gain information about the concentration of GHBPs in children with insulin-dependent diabetes mellitus (IDDM), we measured GHBP in the serum of 46 children with IDDM and compared it to that in 53 healthy control subjects matched for age and sexual maturity. The total GHBP concentration in the group of pubertal and postpubertal IDDM patients was lower than that measured in the control group (mean +/- SEM: 7.8 +/- 0.4 vs. 9.0 +/- 0.5%, P = 0.05). The diabetic children in stages II to IV of puberty had a lower GHBP level compared to their healthy controls (7.6 +/- 0.4 vs. 9.1 +/- 0.5%, P = 0.02), whereas the difference between the diabetic and control group of postpubertal children was not statistically different (8.3 +/- 0.7 vs. 9.7 +/- 0.7%, P = 0.1). In a randomly selected subset of eight patients and eight controls, the concentration of the individual GHBPs (i.e. high affinity and low affinity (GHBP) was estimated by gel chromatography. There was no difference in the low affinity GHBP between the two groups (9.9 +/- 0.6% vs. 9.9 +/- 0.4%), but the high affinity GHBP was less in the diabetic group than in the control group (10.5 +/- 0.9 vs. 15.6 +/- 1.0%, P less than 0.01). In the diabetic group, there was no correlation between the GHBP levels and age, duration of diabetes, hemoglobin A1, or insulin dose. We conclude that in IDDM there is less of the high affinity GHBP, suggesting a decrease in the number of GH receptors in these patients. This decrease may contribute to GH resistance manifesting as decreased insulin-like growth factor-I levels despite high GH levels in patients with IDDM.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1548360     DOI: 10.1210/jcem.74.4.1548360

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  9 in total

Review 1.  Circulating growth hormone binding proteins.

Authors:  G Baumann; M A Shaw; K Amburn
Journal:  J Endocrinol Invest       Date:  1994-01       Impact factor: 4.256

Review 2.  The endocrine system in diabetes mellitus.

Authors:  Hisham Alrefai; Hisham Allababidi; Shiri Levy; Joseph Levy
Journal:  Endocrine       Date:  2002-07       Impact factor: 3.633

Review 3.  The glomerular podocyte as a target of growth hormone action: implications for the pathogenesis of diabetic nephropathy.

Authors:  P Anil Kumar; Frank C Brosius; Ram K Menon
Journal:  Curr Diabetes Rev       Date:  2011-01

Review 4.  Growth Hormone and Counterregulation in the Pathogenesis of Diabetes.

Authors:  Xuehong Dong; Lei Su; Mary-Elizabeth Patti
Journal:  Curr Diab Rep       Date:  2022-08-24       Impact factor: 5.430

5.  LEPROT and LEPROTL1 cooperatively decrease hepatic growth hormone action in mice.

Authors:  Thierry Touvier; Françoise Conte-Auriol; Olivier Briand; Céline Cudejko; Réjane Paumelle; Sandrine Caron; Eric Baugé; Yves Rouillé; Jean-Pierre Salles; Bart Staels; Bernard Bailleul
Journal:  J Clin Invest       Date:  2009-11-09       Impact factor: 14.808

6.  Serum levels of growth hormone-binding protein and insulin-like growth factor I in children and adolescents with type 1 (insulin-dependent) diabetes mellitus.

Authors:  G Massa; L Dooms; R Bouillon; M Vanderschueren-Lodeweyckx
Journal:  Diabetologia       Date:  1993-03       Impact factor: 10.122

7.  Recruitment of a repressosome complex at the growth hormone receptor promoter and its potential role in diabetic nephropathy.

Authors:  P M Gowri; J H Yu; A Shaufl; M A Sperling; R K Menon
Journal:  Mol Cell Biol       Date:  2003-02       Impact factor: 4.272

Review 8.  Growth abnormalities in children with type 1 diabetes, juvenile chronic arthritis, and asthma.

Authors:  Cosimo Giannini; Angelika Mohn; Francesco Chiarelli
Journal:  Int J Endocrinol       Date:  2014-02-04       Impact factor: 3.257

Review 9.  The insulin-like growth factor system in chronic kidney disease: Pathophysiology and therapeutic opportunities.

Authors:  Youngman Oh
Journal:  Kidney Res Clin Pract       Date:  2012-01-17
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.